1. C

    A multi-omics based anti-inflammatory immune signature characterizes Long COVID Syndrome (Kovarik et al, 2022)

    Abstract To investigate Long COVID Syndrome (LCS) pathophysiology, we performed an exploratory study with blood plasma derived from three groups: 1) healthy vaccinated individuals without SARS-CoV-2 exposure; 2) asymptomatic recovered patients at least three months after SARS-CoV-2 infection...